<DOC>
	<DOCNO>NCT02214654</DOCNO>
	<brief_summary>The purpose study compare clopidogrel ticagrelor one strong anti-inflammation effect protect type 2 diabetes-induced vascular damage .</brief_summary>
	<brief_title>A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage</brief_title>
	<detailed_description>i- Verify study inclusion exclusion criterion visit 1. ii- Inform patient ( verbally write ) caregiver ( consider necessary patient 's consent ) characteristic study confirm agreement participate signing informed consent document . iii- Assist patient assessment , record information case report form . Based data get case report form , assign patient experimental control group stratify randomization . ⅳ- At visit 2 obtain blood sample peripheral vessel analyze density CECs , sCD40L hs-CRP flow cytometry ( FCM ) , ELISA particle-enhanced turbidimetric immunoassay . ⅴ- All patient give aspirin 100mg/qd orally experimental group give ticagrelor 90mg/bid control group clopidogrel 75mg/qd 30 day . ⅵ- At visit 3 repeat step ⅳ make comparison number CECs CD40L two group , finish statistic analysis .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Provision inform consent prior study specific procedure . 2 . A previous new diagnosis type 2 diabetes mellitus , document one follow criteria:1）Hemoglobin A1c ≥6.5 % diagnosis ; 2 ) Fasting plasma glucose ( FPG ) ≥126mg/dL ( 7.0 mmol/L ) ; 3 ) Twohour plasma glucose≥200 mg/dL ( 11.1 mmol/L ) oral glucose tolerance test ( OGTT ) ; 4 ) classic symptom hyperglycemia hyperglycemic crisis , random plasma glucose≥200mg/dL ( 11.1 mmol/L ) ( confirm repeat test ) 3 . A previous new diagnosis stable CAD accord ICD 10 least 6 month , document follow criterion : 1 ) Stable angina ; 2 ) No AMI NSTEACS within 1 month ; ( ) 3 ) EKG ischemic STsegment ( ) Twave change ; ( ) 4 ) coronory artery stenosis ≥50 % view coronary CTA coronary angiography 4 . No medication history clopidogrel/ticagrelor least 1 month 5 . Female male , race , aged≥18 year , pregnant . 1 . Blood pressure＞160/100 mm Hg ; 2 . Hypercholesterolemia ( LDLc ＞240mg/dl ) ; 3 . Hemoglobin A1c ≥ 10 % ; 4 . Platelet count le 10*10^9/L hemoglobin &lt; 10 g/dL ; 5 . Intolerance allergy clopidogrel/ticagrelor excipients ; 6 . Patient known inflammatory condition antiinflammatory drug therapy ; 7 . Second third degree atrioventricular block ; 8. chronic obstructive lung disease asthma ; 9 . Creatinine＞2 mg/dl ; 10 . Malignancy ; 11 . Moderate severe hepatic impairment ; 12 . History intracranial haemorrhage ; 13 . Active pathological bleeding ; 14 . Pregnancy lactation ; 15 . Any condition increase risk noncompliance lose followup ; 16 . Medicine history potent CYP3A4 inhibitor ( ketoconazole , clarithromycin , etc . ) ; 17 . No provision inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>